PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Delisted

PRVL was delisted on the 21st of January, 2021.

38 hedge funds and large institutions have $349M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+38
Holders Change %
% of All Funds
0.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
38
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Goldman Sachs
26
Goldman Sachs
New York
$497K +$497K +37,642 New
GGHC
27
Gilder Gagnon Howe & Co
New York
$389K +$389K +29,480 New
CSS
28
Cubist Systematic Strategies
Connecticut
$230K +$230K +17,425 New
SG Americas Securities
29
SG Americas Securities
New York
$194K +$194K +14,706 New
Northern Trust
30
Northern Trust
Illinois
$188K +$188K +14,239 New
Morgan Stanley
31
Morgan Stanley
New York
$166K +$166K +12,538 New
UBS Group
32
UBS Group
Switzerland
$138K +$138K +10,485 New
PHK
33
Point72 Hong Kong
Hong Kong
$106K +$106K +8,000 New
Blackstone Inc
34
Blackstone Inc
New York
$66K +$66K +5,000 New
TRCT
35
Tower Research Capital (TRC)
New York
$8K +$8K +614 New
CCA
36
Catalyst Capital Advisors
New York
$7K +$7K +500 New
FIA
37
FNY Investment Advisers
New York
$7K +$7K +600 New
Bank of America
38
Bank of America
North Carolina
$3K +$3K +200 New